Roche launches newborn screening test for three severe genetic conditions

BERLIN, Sept. 30, 2026 // -- Roche (SIX:RO, ROP; OTCQX: RHHBY) announced today that TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix® Newborn TREC/SMN1/HBB kit, an in vitro diagnostic test for newborn screening in countries accepting the CE mark. The test simultan…